Prof. Mamoun Elawad, MD, MBBS, FRCPCH, MRCP, CCST
Prof. Elawad has his training in Pediatric gastroenterology at Great Ormond Street, Chelsea and Westminster Hospital, Oxford John Radcliff Hospital and King’s College Hospital. He worked as a consultant Paediatric gastroenterologist at University Hospital of Wales and Birmingham Children’s Hospital before he rejoined Great Ormond Street Hospital in 2002 as a consultant gastroenterologist and senior lecturer at the University College of London. He joined Sidra Medicine in 2014 as a Chief of Paediatric Gastroenterology and a section head of inflammatory bowel disorders.
He has been the head of the department at Great Ormond Street since 2007 until he joined Sidra Medicine. During this period, he led the department to the largest ever expansion and restructure of the service to attract 3 main nationally funded programs that included gut rehabilitation and small bowel transplant, intestinal pseudo-obstruction. He then became the founder and the director of the first worldwide pioneering program for Hematopoietic Stem Cell Transplant for autoimmune and inflammatory gut diseases. He was also the director of the department international collaboration “ImproveCareNow” at GOSH and later on at Sidra Medicine, which involves more than 100 pediatric gastrointestinal units in the United States, with GOSH & Sidra Medicine being the only centers outside the United States. This collaboration sets the standards of management of children with inflammatory bowel diseases and is a unique quality improvement and research tool that attracts more than 30,000 patients. He was also the co-founder of the European GENIUS group that oversees the diagnosis and the treatment of children with Early onset inflammatory bowel diseases.
Prof. Elawad was a member of the clinical committee of ImproveCareNow, member of the council of CAPGAN and member of the inflammatory bowel disease working group for BSPGHAN. He was also the co-author of the worldwide strategy for implementation of pediatric endoscopy produced by the FISPGHAN.
Prof. Elawad has been a professor of clinical pediatrics at Qatar University and adjunct professor at WCM Qatar. His main research areas of interest are autoimmune gut disorders, genetics of inflammatory bowel disease, Early Onset Inflammatory Bowel Disease and GI food allergy. He has more than 50 publications in the field of inflammatory bowel disease, molecular genetics of early onset inflammatory bowel disease, Hematopoietic Stem Cell Transplant for refractory inflammatory bowel diseases and food allergy.
